Skip to content
AnalystLens
Back to CMEBalance Sheet

CME GROUP INC. Cash & Equivalents 2006-2026 | CME

Annual FY2006–FY2025 · quarterly through Q2 FY2026

Latest annual · FY2025

$4.42B

+52.7%YoY vs FY2024Source: 10-KFY2025

From $969.5M in FY2006 to $4.42B in FY2025: 4.6× in 19 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$2.4B+70.2%$2.1B+8.2%Not reportedNot reported
FY25$1.4B−2.2%$2.0B+10.7%$2.4B+5.4%$4.4B+52.7%
FY24$1.4B−8.2%$1.8B−4.8%$2.3B+1.0%$2.9B−0.7%
FY23$1.6B−23.5%$1.9B0.0%$2.3B+8.0%$2.9B+7.1%
FY22$2.0B+118.5%$1.9B+73.9%$2.1B+46.0%$2.7B−4.0%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

+22.0%

FY2020
$1.63B
FY2025
$4.42B

5 years selected · on the chart

01—History

Cash & Equivalents History

Year-over-year comparison from 10-K annual reports

  20. $4.42B
YoY changeLargest recent move+73.6%in FY21Latest +52.7%

1 older move runs past ±100% (largest +228.2%); point at, tap or drag across the bars to read one.

02—Ledger

Cash & Equivalents, period by period

PeriodValueChangeSource
FY2025$4.42B+52.7%10-K
FY2024$2.89B−0.7%10-K
FY2023$2.91B+7.1%10-K
FY2022$2.72B−4.0%10-K
FY2021$2.83B+73.6%10-K
FY2020$1.63B+5.3%10-K
FY2019$1.55B+12.9%10-K
FY2018$1.37B−27.8%10-K
FY2017$1.90B+1.9%10-K
FY2016$1.87B+10.4%10-K
FY2015$1.69B+23.9%10-K
FY2014$1.37B−44.7%10-K
FY2013$2.47B+53.9%10-K
FY2012$1.60B+54.0%10-K
FY2011$1.04B+21.9%10-K
FY2010$855.2M+228.2%10-K
FY2009$260.6M−12.5%10-K
FY2008$297.9M−64.8%10-K
FY2007$845.3M−12.8%10-K
FY2006$969.5M—10-K

03—Questions

What is cash & equivalents?

Cash and cash equivalents can be defined as the most liquid assets on a company's balance sheet, including cash on hand and short-term investments maturing within 90 days.

What is CME GROUP INC.'s current cash & equivalents?

CME GROUP INC. (CME) annual cash & equivalents for 2025 was $4.42B, a 52.71% increase from 2024. CME GROUP INC. cash & equivalents for the quarter ending June 30, 2026 was $2.14B.

What was CME GROUP INC.'s cash & equivalents in 2024?

CME GROUP INC. annual cash & equivalents for 2024 was $2.89B, a 0.67% decline from 2023.

What was CME GROUP INC.'s cash & equivalents in 2023?

CME GROUP INC. annual cash & equivalents for 2023 was $2.91B, a 7.05% increase from 2022.

What is CME GROUP INC.'s 5-year cash & equivalents CAGR?

CME GROUP INC. cash & equivalents grew at a compound annual growth rate (CAGR) of 22.02% from FY2020 to FY2025, going from $1.63B to $4.42B over 5 years.

Company
CME GROUP INC.
Ticker
CME
Sector
Other
Industry
Security & Commodity Brokers, Dealers, Exchanges & Services
View company profile →